MSCIW 103PRO0226U (0119U) | Stock Overview & Key Data
MSCIW 103PRO0226U | Micro-cap
MSCIW 103PRO0226U | Micro-cap
MSCIW 103PRO0226U Performance Comparison
Stock Range
Today's Range
Low: $117.96
High: $117.96
on August 22, 2025
52 Week Range
Low: $108.90
High: $117.98
on September 12, 2024
on August 21, 2025
All-Time High: $117.96 on August 22, 2025
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Returns and Earnings
Return on Assets (TTM)
N/A
Return on Equity (TTM)
N/A
EBITDA
$0
Net Income (TTM)
$0
Growth
Revenue (TTM)
Revenue Per Share (TTM)
N/A
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| MSCIW 103PRO0226U 0119U | N/A Micro-cap | -0.02% | -0.02% | 1.62% | 3.24% | 4.61% | 6.94% | 19.67% | 19.67% |
| UBS AG, London 0022U | N/A Micro-cap | 0.09% | 0.47% | 3.30% | 3.04% | 3.93% | 8.73% | 24.56% | 24.56% |
| GLDFP 100PRO0825U 0110U | N/A Micro-cap | 0.08% | 0.35% | 1.16% | 2.41% | 2.94% | 6.55% | 22.72% | 22.72% |
| Ark Genomic 1ARKG | N/A Micro-cap | 8.94% | 11.43% | 16.77% | 6.56% | -1.02% | 3.72% | -96.66% | -96.93% |
| 1Ark Innovation 1ARKK | N/A Micro-cap | 6.57% | 10.36% | 20.32% | 44.57% | 28.62% | 68.78% | 49.20% | 153.74% |
| Legal & General 1ARKW | N/A Micro-cap | 4.79% | 8.04% | 16.57% | 51.15% | 36.81% | 90.65% | 3,840.00% | 2,264.00% |
Ownership & Short Interest
Insider Ownership
N/A
Institutional Ownership
N/A
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
320
Average 90-Day Volume
387
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is 0119U's 52-week high and low?
- In the last 52 weeks, MSCIW 103PRO0226U reached a high of $117.98 (on August 21, 2025) and a low of $108.90 (on September 12, 2024).
- What is the market cap and P/E ratio for 0119U?
- Curious about MSCIW 103PRO0226U's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does 0119U pay dividends? If so, what's the yield?
- As for dividends, MSCIW 103PRO0226U isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are MSCIW 103PRO0226U's main competitors or similar companies to consider before investing?
When looking at MSCIW 103PRO0226U, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UBS AG, London
0022UN/A N/A N/A 8.73% 24.56% GLDFP 100PRO0825U
0110UN/A N/A N/A 6.55% 22.72% Ark Genomic
1ARKGN/A N/A N/A 3.72% -96.66% 1Ark Innovation
1ARKKN/A N/A N/A 68.78% 49.20% Legal & General
1ARKWN/A N/A N/A 90.65% 3,840.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for MSCIW 103PRO0226U? (e.g., ROE, Debt/Equity)
- To get a sense of MSCIW 103PRO0226U's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for 0119U?
- Looking at MSCIW 103PRO0226U's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of 0119U stock is held by insiders and institutions?
- Wondering who owns MSCIW 103PRO0226U stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.